Matteo Calgaro

Appearances

ORAL SODIUM BUTYRATE ADMINISTRATION SIGNIFICANTLY IMPROVES CLINICAL OUTCOME AND QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE BY MODIFYING THE GUT MICROBIOTA – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY
Date
May 19, 2024
Background and Objectives: Butyrate, a short-chain fatty acid (SCFA), is crucial as the primary energy source for colonocytes. The deficiency of SCFAs has been theorized to lead to mucosal hypoplasia and colitis…
Speakers
Sonia Facchin
Matteo Calgaro
Mattia Pandolfo
Nicola Vitulo
Presenter
Edoardo Savarino